ScholarIQanswers from OpenAlex & ORCID
Howard A. Liebman
ResearcherPublications, citations & collaboration network
Howard A. Liebman is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Howard A. Liebman have?
ScholarIQindexed works
Howard A. Liebman has 228 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Howard A. Liebman have?
ScholarIQcitation count
Howard A. Liebman has 16,205 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Howard A. Liebman?
ScholarIQh-index
Howard A. Liebman has an h-index of 57 in OpenAlex.
What is the i10-index of Howard A. Liebman?
ScholarIQi10-index
Howard A. Liebman has an i10-index of 120 in OpenAlex.
What is the ORCID of Howard A. Liebman?
ScholarIQorcid
The ORCID for Howard A. Liebman is on the source record.
What is the OpenAlex record for Howard A. Liebman?
ScholarIQopenalex
The OpenAlex for Howard A. Liebman is on the source record.
What are the most-cited papers on Howard A. Liebman?
ScholarIQmost cited works
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Alok A. Khorana, Gerald A. Soff, Ajay K. Kakkar, Saroj Vadhan‐Raj, Hanno Riess, Ted Wun, Michael B. Streiff, David García, Howard A. Liebman, Chandra P. Belani, Eileen M. O’Reilly, Jai N. Patel, Habte Yimer, Peter Wildgoose, Paul Burton, Ujjwala Vijapurkar, Simrati Kaul, John W. Eikelboom, Robert D. McBane, Kenneth A. Bauer, Nicole M. Kuderer, Gary H. Lyman
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge, Corinne Frère, Jean M. Connors, Cihan Ay, Alok A. Khorana, Andrés J. Muñoz Martín, Benjamin Brenner, Ajay K. Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monréal, Henri Bounameaux, Ingrid Pabinger, James D. Douketis, Walter Ageno, Fernando Ajauro, Kamal R. Al-Aboudi, Thierry Alcindor, Thierry André, Pantep Angchaisuksiri, Darko Antić, Juan I. Arcelus, Eric Assénat, Kenneth A. Bauer, Ali Bazarbachii, Ilham Benzidia, Jan Beyer‐Westendorf, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Alain Carpentier, Gabriela Cesarman‐Maus, Joydeep Chakbrabartty, Hugo Clemente, J. Connault, Ludovic Doucet, C. Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles W. Francis, Enrique Gallardo, Thomas Gary, Jean‐Christophe Gris, Cecilia Guillermo, A. Hij, Russel Hull, Takayuki Ikezoe, Luis Jara‐Palomares, Nigel S. Key, Jamilya Khrizroeva, Maral Koolian, Florian Länger, C. Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard A. Liebman, Luisa Lopes Dos Santos, Duarte Machado, Isabelle Madelaine, А. D. Makatsariya, Mario Mandalà, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillón, E. Messas, António Moreira, Ahmet Muzaffer Demir, Arlette Ndour, Michel N'Guessan, Remedios Otero, Vanessa Pachón Olmos, Ana Pais, Florian Posch, Matthias Preusser, H. Riess, Marc Righini, Cynthia Rothschild, André Roussin, José Antonio Rueda-Camino, Pedro Ruiz‐Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald A. Soff, Hans Stricker, Vicky Tagalakis, Alì Taher, Toussaint Toutou, Javier Trujillo‐Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Jeffrey I. Zwicker, Benjamin L. Schlechter, Jack D. Stopa, Howard A. Liebman, Anita Aggarwal, Mäneka Puligandla, Thomas Caughey, Kenneth A. Bauer, Nancy B. Kuemmerle, Ellice Wong, Ted Wun, Marilyn McLaughlin, Manuel Hidalgo, Donna Neuberg, Bruce Furie, Robert Flaumenhaft, on behalf of CATIQ Investigators